Thomas DL - Search Results

1

Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitis.

Flexner C, Thomas DL, Swindells S. Flexner C, et al. Among authors: thomas dl. Curr Opin HIV AIDS. 2019 Jan;14(1):13-20. doi: 10.1097/COH.0000000000000510. Curr Opin HIV AIDS. 2019. PMID: 30394948 Review.

2

Hepatitis C in the HIV-Infected Person.

Sulkowski MS, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. Ann Intern Med. 2003 Feb 4;138(3):197-207. doi: 10.7326/0003-4819-138-3-200302040-00012. Ann Intern Med. 2003. PMID: 12558359 Review.

3

Hepatitis C in the HIV-infected patient.

Sulkowski MS, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. Clin Liver Dis. 2003 Feb;7(1):179-94. doi: 10.1016/s1089-3261(02)00074-0. Clin Liver Dis. 2003. PMID: 12691466 Review.

4

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. AIDS. 2005 Mar 24;19(6):585-92. doi: 10.1097/01.aids.0000163935.99401.25. AIDS. 2005. PMID: 15802977

5

A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.

Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. Mehta SH, et al. Among authors: thomas dl. AIDS. 2005 Oct;19 Suppl 3:S179-89. doi: 10.1097/01.aids.0000192088.72055.90. AIDS. 2005. PMID: 16251816 Review.

6

Options for treatment of hepatitis C in HIV-infected persons.

Thomas DL. Thomas DL. J Hepatol. 2006;44(1 Suppl):S40-3. doi: 10.1016/j.jhep.2005.11.011. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16356578 Review.

7

Growing importance of liver disease in HIV-infected persons.

Thomas DL. Thomas DL. Hepatology. 2006 Feb;43(2 Suppl 1):S221-9. doi: 10.1002/hep.21033. Hepatology. 2006. PMID: 16447263 Review.

8

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.

Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Mehta SH, et al. Among authors: thomas dl. AIDS. 2006 Nov 28;20(18):2361-9. doi: 10.1097/QAD.0b013e32801086da. AIDS. 2006. PMID: 17117023

9

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.

Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. AIDS. 2007 Oct 18;21(16):2209-16. doi: 10.1097/QAD.0b013e3282f10de9. AIDS. 2007. PMID: 18090048

10

The challenge of hepatitis C in the HIV-infected person.

Thomas DL. Thomas DL. Annu Rev Med. 2008;59:473-85. doi: 10.1146/annurev.med.59.081906.081110. Annu Rev Med. 2008. PMID: 18186707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

764 results

Search Page

Filters